Modulari-T
YC W23Montreal, CA · Founded 2021 · 4 employees · 1 known investors
Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
BiotechDeep TechHealthtechMedical DevicesGene TherapyCell TherapySynthetic BiologyOncologyin /modulari-t-bio/@ycombinator
Founders & leadership· Y Combinator alumni (W23)
David WhiteinFounder
Stephanie MokinFounder